HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-Producing cells or APCs

Journal of Immunology

Volumn 193, Issue 7, 2014, Pages 3538-3548

  Royle, Caroline M ^a   Graham, David R ^b   Sharma, Simone ^c   Fuchs, Dietmar ^d   Boasso, Adriano ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; INTERFERON; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 9; ALPHA INTERFERON;

ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; LYMPHOCYTE ACTIVATION; NONHUMAN; PATHOGENICITY; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS LOAD; DENDRITIC CELL; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; PATHOLOGY; PLASMA CELL;

CELL DIFFERENTIATION; DENDRITIC CELLS; FEMALE; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; INTERFERON-ALPHA; MALE; PLASMA CELLS;

EID: 84907202618     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400860     Document Type: Article

References (51)

1. Picker, L. J., and D. I. Watkins. 2005. HIV pathogenesis: the first c ut is the deepest. Nat. Immunol. 6: 430-432.
2. Sabado, R. L., M. O'Brien, A. Subedi, L. Qin, N. Hu, E. Taylor, O. Dibben, A. Stacey, J. Fellay, K. V. Shianna, et al. 2010. Evidence of dysregulation of dendritic cells in primary HIV infection. Blood 116: 3839-3852.
3. Boasso, A., A. W. Hardy, S. A. Anderson, M. J. Dolan, and G. M. Shearer. 2008. HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation. PLoS ONE 3: e2961.
4. Boasso, A., A. W. Hardy, A. L. Landay, J. L. Martinson, S. A. Anderson, M. J. Dolan, M. Clerici, and G. M. Shearer. 2008. PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes. Clin. Immunol. 129: 132-134.
5. Boasso, A., C. M. Royle, S. Doumazos, V. N. Aquino, M. Biasin, L. Piacentini, B. Tavano, D. Fuchs, F. Mazzotta, S. Lo Caputo, et al. 2011. Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis. Blood 118: 5152-5162.
6. Boasso, A., J. P. Herbeuval, A.W. Hardy, S. A. Anderson, M. J. Dolan, D. Fuchs, and G. M. Shearer. 2007. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 109: 3351-3359.
7. Le, T., E. J. Wright, D. M. Smith, W. He, G. Catano, J. F. Okulicz, J. A. Young, R. A. Clark, D. D. Richman, S. J. Little, and S. K. Ahuja. 2013. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N. Engl. J. Med. 368: 218-230.
8. Fidler, S., K. Porter, F. Ewings, J. Frater, G. Ramjee, D. Cooper, H. Rees, M. Fisher, M. Schechter, P. Kaleebu, et al.; SPARTAC Trial Investigators. 2013. Short-course antiretroviral t herapy in primary HIV infection. N. Engl. J. Med. 368: 207-217.
9. Sáez-Cirión A.,C. Bacchus,L. Hocqueloux,V. Avettand-Fenoel,I. Girault,C. Lecuroux,V. Potard,P. Versmisse,A. Melard,T. Prazuck,et al., ANRS VISCONTI Study Group, 2013, Post-treatment HIV-1 controllers with a longterm virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study, PLoS Pathog., 9, e1003211.
10. Jain, V., W. Hartogensis, P. Bacchetti, P. W. Hunt, H. Ha tano, E. Sinclair, L. Epling, T. H. Lee, M. P. Busch, J. M. McCune, et al. 2013. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J. I nfect. Dis. 208: 1202-1211.
11. Berrey, M. M., T. Schacker, A. C. Collier, T. Shea, S. J. Brodie, D. Mayers, R. Coombs, J. Krieger, T. W. Chun, A. Fauci, et al. 2001. Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS. J. Infect. Dis. 183: 1466-1475.
12. Nyamweya, S., A. Hegedus, A. Jaye, S. Rowland-Jones, K. L. Flanagan, and D. C. Macallan. 2013. Comparing HIV-1 and HIV-2 infection: lessons for viral immunopathogenesis. Rev. Med. Virol. 23: 221-240.
13. Guyader, M., M. Emerman, P. Sonigo, F. Clavel, L. Montagnier, and M. Alizon. 1987. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 326: 662-669.
14. Andersson, S., H. Norrgren, Z. da Silva, A. Biague, S. Bamba, S. Kwok, C. Christopherson, G. Biberfeld, and J. Albert. 2000. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch. Intern. Med. 160: 3286-3293.
15. Marlink, R., P. Kanki, I. Thior, K. Travers, G. Eisen, T. Siby, I. Traore, C. C. Hsieh, M. C. Dia, E. H. Gueye, et al. 1994. Reduced rate of disease development aft er HIV-2 infection as compared to HIV-1. Science 265: 1587-1590.
16. Sousa, A. E., J. Carneiro, M. Meier-Schellersheim, Z. Grossman, and R. M. Victorino. 2002. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169: 3400-3406.
17. Cavaleiro, R., A. P. Baptista, R. S. Soares, R. Tendeiro, R. B. Foxall, P. Gomes, R. M. Victorino, and A. E. Sousa. 2009. Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease. PLoS Pathog. 5: e1000667.
18. Cavaleiro, R., R. Tendeiro, R. B. Foxall, R. S. Soares, A. P. Baptista, P. Gomes, E. Valadas, R. M. Victorino, and A. E. Sousa. 2013. Monocyte and myeloid dendritic cell activation occurs throughout HIV type 2 infection, an attenuated form of HIV disease. J. Infect. Dis. 207: 1730-1742.
19. Martinez-Steele, E., A. A. Awasana, T. Corrah, S. Sabally, M. van der Sande, A. Jaye, T. Togun, R. Sarge-Njie, S. J. McConkey, H. Whittle, and M. F. Schim van der Loeff. 2007. Is HIV-2-induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic. AIDS 21: 317-324.
20. Popper, S. J., A. D. Sarr , A. Guèye-Ndiaye, S. Mboup, M. E. Essex, and P. J. Kanki. 2000. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo. J. Virol. 74: 1554-1557.
21. Ondondo, B. O., S. L. Rowland-Jones, L. Dorrell, K. Peterson, M. Cotten, H. Whittle, and A. Jaye. 2008. Comprehensive analysis of HIV Gag-specific IFN-g response in HIV-1-and HIV-2-infected asymptomatic patien ts from a clinical cohort in The Gambia. Eur. J. Immunol. 38: 3549-3560.
22. Foxall, R. B., C. S. Cortesa ?o, A. S. Albuquerque, R. S. Soares, R. M. Victorino, and A. E. Sousa. 2008. Gag-specif ic CD4+ T-cell frequency is inversely correlated with proviral load and directly correlated with immune activation in infection with human immunodeficiency virus type 2 (HIV-2) but not HIV-1. J. Virol. 82: 9795-9799.
23. Zheng, N. N., N. B. Kiviat, P. S. Sow, S. E. Hawes, A. Wilson, H. Diallo-Agne, C. W. Critchlow, G. S. Gottlieb, L. Musey, and M. J. McElrath. 2004. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1-and HIV-2-infected individuals in Senegal. J. Virol. 78: 13934-13942.
24. Duvall, M. G., A. Jaye, T. Dong, J. M. Brenchley, A. S. Alabi, D. J. Jeffries, M. van der Sande, T. O. Togun, S. J. McConkey, D. C. Douek, et al. 2006. Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection. J. Immunol. 176: 6973-6981.
25. So usa, A. E., A. F. Chaves, A. Loureiro, and R. M. Victorino. 2001. Comparison of the frequency of interleukin (IL)-2-, interferon-g-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct cl inical outcomes. J. Infect. Dis. 184: 552-559.
26. Duvall, M. G., M. L. Precopio, D. A. Ambrozak, A. Jaye, A. J. McMichael, H. C. Whittle, M. Roederer, S. L. Rowland-Jones, and R. A. K oup. 2008. Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur. J. Immunol. 38: 350-363.
27. de Silva, T. I., Y. Peng, A. Leligdowicz, I. Zaidi, L. Li, H. Griffin, M. E. Blai s, T. Vincent, M. Saraiva, L. M. Yindom, et al. 2013. Correlates of T-cell-mediated viral control and phenotype of CD8+ T cells in HIV-2, a naturally contained human retroviral infection. Blood 121: 4330-4339.
28. Bangham, C. R. 2009. CTL quality and the control of human retroviral infections. Eur. J. Immunol. 39: 1700-1712.
29. Widner, B., E. R. Werner, H. Schennach, H. Wachter, and D. Fuchs. 1997. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin. Chem. 43: 2424-2426.
30. Beignon A. S.,K. McKenna,M. Skoberne,O. Manches,I. DaSilva,D. G. Kavanagh, M. Larsson,R. J. Gorelick,J. D. Lifson,N. Bhardwaj., 2005, Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest., 115, 3265-3275.
31. Herbeuval, J. P., A. W. Hardy, A. Boasso, S. A. Anderson, M. J. Dolan, M. Dy, and G. M. Shearer. 2005. Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-p roducing plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. USA 102: 13974-13979.
32. O'Brien, M., O. Manches, R. L. Sabado, S. J. Baranda, Y. Wang, I. Marie, L. Rolnitzky, M. Markowitz, D. M. Margolis, D. Levy, and N. Bhardwaj. 2011. Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-a-producing and partially matured phenotype. J. Clin. Invest. 121: 1088-1101.
33. Jaehn, P. S., K. S. Zaenker, J. Schmitz, and A. Dzionek. 2008. Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon. Eur. J. Immunol. 38: 1822-1832.
34. Leligdowicz, A., L. M. Yindom, C. Onyango, R. Sarge-Njie, A. Alabi, M. Cotten, T. Vincent, C. da Costa, P. Aaby, A. Jaye, et al. 2007. Robust Gagspecific T cell responses characterize viremia control in HIV-2 infection. J. Clin. Invest. 117: 3067-3074.
35. Machuca, A., L. Ding, R. Taffs, S. Lee, O.Wood, J. Hu, and I. Hewlett. 2004. HIV type 2 primary isolates induce a lower degree of apoptosis "in vitro" compared with HIV type 1 primary isolates. AIDS Res. Hum. Retroviruses 20: 507-512.
36. Michel, P., A. T. Balde, C. Roussilhon, G. Aribot, J. L. Sarthou, and M. L. Gougeon. 2000. Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: correlation of T cell apoptosis with beta2 microglobulin concentration and disease evoluti on. J. Infect. Dis. 181: 64-75.
37. Kadowaki, N., S. Antonenko, J. Y. Lau, and Y. J. Liu. 2000. Natural interferon a/b-producing cells link innate and adaptive immunity. J. Exp. Med. 192: 219-226.
38. Munn, D. H., and A. L. Mellor. 2007. Indoleamine 2,3-dioxygenase and tumorinduced tolerance. J. Clin. Invest. 117: 1147-1154.
39. Manches, O., D. Munn, A. Fallahi, J. Lifson, L. Chaperot, J. Plumas, and N. Bhardwaj. 2008. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. J. Clin. Invest. 118: 3431-3439.
40. Nilsson, J., A. Boasso, P. A. Velilla, R. Zhang, M. Vaccari, G. Franchini, G. M. Shearer, J. Andersson, and C. Chougnet. 2006. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 108: 3808-3817.
41. Huengsberg, M., J. B. Win er, M. Gompels, R. Round, J. Ross, and M. Shahmanesh. 1998. Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients. Clin. Chem. 44: 858-862.
42. Fuchs, D. , A. A. Möller, G. Reibnegger, E. R. Werner, G. Werner-Felmayer, M. P. Dierich, and H. Wachter. 1991. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunode ficiency virus type 1 infection. Immunol. Lett. 28: 207-211.
43. McKenna, K., A. S. Beignon, and N. Bhardwaj. 2005. Plasmacytoid dendritic cells: linking innate and adaptive immunity. J. Virol. 79: 17-27.
44. Boasso, A., and G. M. Shearer. 2008. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin. Immunol. 126: 235-242.
45. Herbeuval, J. P., J. C. Grivel, A. Boasso, A. W. Hardy, C. Chougnet, M. J. Dolan, H. Yagita, J. D. Lifson, and G. M. Shearer. 2005. CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/ DR5-mediated apoptosis. Blood 106: 3524-3531.
46. Baenziger, S., M. Heikenwalder, P. Johansen, E. Schlaepfer, U. Hofer, R. C. Miller, S. Diemand, K. Honda, T. M. Kundig, A. Aguzzi, and R. F. Speck. 2009. Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood 113: 377-388.
47. Fraietta, J. A., Y. M. Mueller, G. Yang, A. C. Boesteanu, D. T. Gracias, D. H. Do, J. L. Hope, N. Kathuria, S. E. McGettigan, M. G. Lewis, et al. 2013. Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection. PLoS Pathog. 9: e1003658.
48. Kader, M., A. P. Smith, C. Guiducci, E. R. Wonderlich, D. Normolle, S. C. Watkins, F. J. Barrat, and S. M. Barratt-Boyes. 2013. Blocking TLR7-and TLR9-mediated IFN-A production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infection. PLoS Pathog. 9: e1003530.
49. Creagh, E. M., and L. A. O'Neill. 2006. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27: 352-357.
50. Harman, A. N., J. Lai, S. Turville, S. Samarajiwa, L. Gray, V. Marsden, S. K. Mercier, K. Jones, N. Nasr, A. Rustagi, et al. 2011. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood 118: 298-308.
51. Esbjö rnsson, J., F. Mansson, A. Kvist, P. E. Isberg, S. Nowroozalizadeh, A. J. Biague, Z. J. da Silva, M. Jansson, E. M. Fenyö, H. Norrgren, and P. Medstrand. 2012. Inhibition of HIV-1 dis ease progression by contemporaneous HIV-2 infection. N. Engl. J. Med. 367: 224-232.